|
B-Well,potential new treatment
|
|
6
|
1012
|
June 21, 2024
|
|
Tenofovir amibufenamide vs Vemlidy
|
|
5
|
877
|
April 18, 2024
|
|
Young Investigator Awards for Hepatitis Research
|
|
1
|
240
|
April 6, 2024
|
|
Position Available: Viral Hepatitis Peer Worker (Lived Experience)
|
|
0
|
242
|
April 2, 2024
|
|
Exploratory Hepatitis B dataset: Encouraging new hypotheses
|
|
4
|
490
|
March 31, 2024
|
|
VH2024: Abstract & Scholarship Opportunities
|
|
0
|
193
|
March 11, 2024
|
|
Health & Law Project
|
|
1
|
219
|
March 9, 2024
|
|
Community & Lived Experience Scholarships for VH2024
|
|
3
|
321
|
March 5, 2024
|
|
Positions Available at Hepatitis NSW
|
|
0
|
192
|
February 23, 2024
|
|
Position Available: Casual Multicultural Liver Health Worker
|
|
1
|
215
|
March 1, 2024
|
|
VIR-3434 Phase 1-study made by Vir Biotechnology
|
|
28
|
3129
|
December 21, 2023
|
|
Ab-729 Trial, should I join?
|
|
81
|
3918
|
September 5, 2023
|
|
NMN supplement investigated as a potential cure - “Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B”
|
|
14
|
1796
|
August 19, 2023
|
|
New treatment of HepB maybe ? AGT
|
|
2
|
588
|
July 31, 2023
|
|
Brii Bio results
|
|
2
|
414
|
June 27, 2023
|
|
Vaccitech - HBV002 Study
|
|
4
|
613
|
June 24, 2023
|
|
Arbutus - AB-729 rnai, phase2 results
|
|
1
|
463
|
June 23, 2023
|
|
HepBFoundation Clinical Trials Finder
|
|
0
|
330
|
June 8, 2023
|
|
SCG Cell Therapy to Present Late-Breaking Data
|
|
10
|
828
|
June 8, 2023
|
|
Hepatitis B Voices Australia - New advocacy group
|
|
14
|
1149
|
June 2, 2023
|
|
Cold and blue hands
|
|
12
|
5800
|
May 2, 2023
|
|
Evaluation of Hepatitis B Virus (HBV) DNA Test as Point of Care Tool (HBVPOCT)
|
|
0
|
483
|
April 24, 2023
|
|
Nucs off functional cure
|
|
1
|
623
|
April 4, 2023
|
|
Discovery of a first-in-class orally available HBV cccDNA inhibitor
|
|
4
|
732
|
April 4, 2023
|
|
Lived Experience Treatment Preferences Survey
|
|
1
|
491
|
March 8, 2023
|
|
Call for research participants ($50 reimbursement for time)
|
|
6
|
708
|
February 23, 2023
|
|
Hep B and immunity study - call for participants ($50 reimbursement)
|
|
0
|
446
|
February 2, 2023
|
|
HerberNasvac Therapeutic Vaccine
|
|
3
|
1200
|
January 19, 2023
|
|
Paid research participation - interview with people living with hep B
|
|
0
|
481
|
January 18, 2023
|
|
Is mRNA vaccine the answer?
|
|
2
|
1014
|
January 14, 2023
|